Security key
152309100
Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (CNTA)
CUSIP: 152309100
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Ordinary Shares, nominal value GBP 0.002 per share
- Shares outstanding
- 154,150,943
- Total 13F shares
- 124,413,136
- Share change
- +4,135,887
- Total reported value
- $2,083,915,345
- Put/Call ratio
- 3144%
- Reported price per share
- $16.75
- Number of holders
- 114
- Value change
- +$72,898,202
- Number of buys
- 52
- Number of sells
- 49
Security identity
Holder snapshot
Report period
Q4 2024
Institutions
114
Top holders
10
CNTA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Centessa Pharmaceuticals plc SEC filings
Centessa Pharmaceuticals plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 152309100
Recent filing periods:
Ownership snapshot
Top shareholders of CNTA - Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Medicxi Ventures Manageme...
13D/G signal
—
Evidence rows
50
Latest as of
30 Sep 2024
13F
3/4/5
Lead comparable stake: 13%
Showing 1-8 of 50 holder rows.
Rank 1 holder
Medicxi Ventures Management (Jersey) Ltd
13F
3/4/5
- Ownership
- 13%
- Position
- $319.21M
Rank 2 holder
GENERAL ATLANTIC, L.P.
13F
- Ownership
- 6.3%
- Position
- $154.81M
Rank 3 holder
PERCEPTIVE ADVISORS LLC
13F
- Ownership
- 4.1%
- Position
- $100.45M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd |
13F
3/4/5
Company · 10%+ Owner
|
13%
|
$319,210,880
19,963,157 shares
|
— | 30 Sep 2024 |
| GENERAL ATLANTIC, L.P. |
13F
Company
|
6.3%
|
$154,812,270
9,681,818 shares
|
— | 30 Sep 2024 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
4.1%
|
$100,453,817
6,282,290 shares
|
— | 30 Sep 2024 |
| First Light Asset Management, LLC |
13F
Company
|
3.9%
|
$94,982,711
5,940,132 shares
|
— | 30 Sep 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
3%
|
$74,818,000
4,679,021 shares
|
— | 30 Sep 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
2.7%
|
$67,078,050
4,195,000 shares
|
— | 30 Sep 2024 |
| Vida Ventures Advisors, LLC |
13F
Company
|
2.6%
|
$62,869,770
3,931,818 shares
|
— | 30 Sep 2024 |
| T. Rowe Price Investment Management, Inc. |
13F
Company
|
2.3%
|
$56,861,000
3,556,023 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
114
Shares
124,413,136
Rows loaded
114
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
101
Q4 2024 holders
114
Holder diff
13
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend